Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: John Paulson, Steven Cohen & Sandell Asset Management

Paulson Tripled Shire Stake Before Deal Fell Apart (Finalternatives)
John Paulson clearly did not see the collapse of pharmaceutical giant AbbVie Inc (NYSE:ABBV)’s deal with rival Shire coming. Paulson’s hedge fund nearly tripled its stake in Shire PLC (ADR) (NASDAQ:SHPG) in the months before the $54 billion merger foundered last month. It also opened a position in AbbVie itself during the third quarter, according to a regulatory filing. Those positions took a beating when AbbVie walked away from the deal last month, after the U.S. Treasury Department instituted new rules limiting so-called tax inversions, in which U.S. companies acquire smaller foreign firms to move their headquarters abroad, saving on taxes. Shire is based in Ireland.

best gold ETF

Quindell silent as investors mull MBO amid hedge fund rumours (CityAM)
Insurance services firm Quindell has declined to comment on investor speculation that the company is seeking a cash injection in order to carry out a management buyout (MBO). The firm is reported to be in talks with several hedge funds in a bid to gain fresh capital, and shareholders have flagged up the possibility that the firm’s management may use the money to buy the company. Quindell’s share price has plummeted in recent weeks, and slumped significantly last week after the firm was forced to clarify the details of a share transfer agreement between three of the company’s directors and Equities First Holdings.

Fink’s Hedge Fund ISAM Starts Foreign-Exchange Brokerage (BusinessWeek)
International Standard Asset Management Ltd., the London-based hedge-fund firm run by Stanley Fink, is starting a foreign-exchange brokerage to target institutional investors. The service, IS Prime, will provide prime brokerage, traditional and non-traditional liquidity and risk-management solutions, ISAM said in an e-mailed statement. Jonathan Brewer and Raj Sitlani joined the firm as managing partners from Sucden Financial Ltd., where Brewer was the head of electronic currency trading sales and Sitlani ran global institutional sales.

Perella Weinberg to Close Xerion Hedge Fund (WSJ)
A high-profile hedge-fund manager is throwing in the towel, the latest retreat in an industry that has struggled to navigate this year’s volatile markets. Daniel Arbess, known for his public predictions on macroeconomic trends, said Friday that he is shutting down the $600 million Perella Weinberg Partners Xerion fund that he has managed since 2002. Investors in the fund, which at its peak boasted more than $3 billion under management, will get their money back next month, according to a letter reviewed by The Wall Street Journal.

SAC’s Cohen To Face Wide-Ranging Deposition In Divorce Suit (Law360)
SAC Capital Advisors LP founder Steven Cohen will be deposed next month in a suit claiming he hid assets during a 1990 divorce proceeding and could face broader questions about insider trading at the hedge fund, a New York federal judge said Monday. Judge Loretta Preska said she would allow attorneys for Cohen’s ex-wife Patricia Cohen to question him about “prior acts that are alleged to be untruthful,” including his denial of any role in insider trading at SAC. The hedge fund and eight current and…

Ackman’s win-win (CNBC)

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.